Metabolic syndrome and multiple organ damage in essential hypertension
Cesare Cuspidi1, Cristiana Valerio, Valentina Giudici
1Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milano, Italy. cesare.cuspidi@unimib.it
Insights
Metabolic syndrome (MS) is more common in hypertensive patients with organ damage (OD). A systematic search for cardiac and extra-cardiac OD is valuable in MS patients to identify cardiovascular risks.
Area of Science:
- Cardiology
- Hypertension Research
- Metabolic Syndrome Studies
Background:
- Essential hypertensives often present with metabolic syndrome (MS) and varying degrees of organ damage (OD).
- Understanding the relationship between MS prevalence and the extent of OD is crucial for risk stratification.
- Previous studies have not fully elucidated the association between MS and the number of OD markers in hypertensive patients.
Purpose of the Study:
- To investigate the prevalence of MS in hypertensive patients categorized by the number of organ damage (OD) markers.
- To assess the value of systematically searching for cardiac and extra-cardiac OD in patients with MS.
- To determine if a higher number of OD markers is associated with increased MS prevalence.
Main Methods:
- Analysis of 3119 untreated and treated essential hypertensives from the ETODH registry.
- Patients were evaluated for cardiac (LVH/remodeling), vascular (carotid plaques/IMT), and renal (MA/creatinine) OD markers.
- Subjects were classified into four groups based on the number of OD markers: none, one, two, or three.
Main Results:
- MS prevalence increased progressively with the number of OD markers, showing a 2.3-fold rise in patients with three OD markers compared to those with none.
- Patients with two or three OD markers constituted 53% of those with MS, versus 33% of those without MS (p<0.01).
- The distribution of MS varied across OD groups: 15% (group 0), 32% (group I), 39% (group II), and 14% (group III).
Conclusions:
- A strong association exists between MS and OD in hypertensive patients.
- Clustering of two or three OD markers represents the prevalent cardiovascular phenotype in MS hypertensives.
- Systematic evaluation of cardiac and extra-cardiac OD is recommended for hypertensive patients with MS.
Aim:
We investigated the prevalence of the metabolic syndrome (MS) in hypertensive patients categorized according to the number of markers of organ damage (OD) in order to assess the value of a systematic search for cardiac and extra-cardiac OD in the MS setting.
Methods:
A total of 3119 untreated and treated essential hypertensives included in the Evaluation of Target Organ Damage in Hypertension (ETODH), an observational registry of hypertension-related OD, were considered for this analysis. All patients underwent extensive investigation for left ventricular hypertrophy (LVH) or LV concentric remodeling (cardiac OD), carotid plaques and/or intima-media thickening (vascular OD) and microalbuminuria (MA) and/or increased serum creatinine (renal OD). Subjects were classified as: positive for none (group 0), one (group I), two (group II) or three markers (group III) of OD.
Results:
MS prevalence rates progressively rose across the groups stratified according to the OD score, reaching a 2.3-fold increase in group III compared with their MS counterparts in group 0. The distribution of subjects with and without the MS across the groups was 15% vs 29% (group 0), 32% vs 38% (group I), 39% vs 26% (group II) and 14% vs 7% (group III), respectively. Thus, subjects having two or three markers of OD were 53% among those with MS and 33% (p<0.01) among those without it.
Conclusion:
Our findings indicate a strong association between the MS and OD by showing that a clustering of two or three markers of OD is the prevalent cardiovascular phenotype in MS hypertensives referred to a specialist center and call for a systematic evaluation of cardiac and extracardiac OD in this setting.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension I: Introduction
Coronary Artery Disease I: Introduction
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Type II Diabetes II: Pathophysiology
